I'd like to pay this cheque in, please <a href=" http://www.spellwebdesign.com/sitemap2.html ">viagra eller cialis flashback</a> At least one company has already indicated it will cut prices. Earlier this year, GlaxoSmithKline Plc won approval from the U.S. Food and Drug Administration for Tafinlar, a drug targeting the same mutant genes as Zelboraf, based on a single clinical trial of just 250 patients. It said the drug would cost $7,600 a month, 30 percent less than Zelboraf.